Of 784,185 complete blood cell counts performed during 28 months, 3,841 (0.49%) revealed recent-onset normocytic anemia, including 424 (11.04%) with reticulocyte counts of 2% (0.02) or more.

Featuring articles on neoadjuvant therapy for lung cancer, a phase 2 trial of retatrutide for obesity, systemic inflammation and normocytic anemia in DOCK11 deficiency, and on the social ...